NASDAQ : HUMA
Humacyte, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.4112 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 114.23M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Humacyte, Inc. (HUMA) reported revenue of 2.12M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 2.12M | 2.04M | 1.56M | 1.26M | ||
| Cost of Revenue | 81.50M | 78.40M | 88.60M | 76.55M | 63.26M | 61.34M |
| Gross Profit | -79.37M | -76.37M | -88.60M | -76.55M | -61.70M | -60.08M |
| Selling, General & Admin | 31.08M | 31.07M | 25.80M | 20.39M | 22.88M | 21.13M |
| Operating Expenses | 31.08M | 31.07M | 25.80M | 20.39M | 22.88M | 21.13M |
| Operating Income | -110.46M | -107.44M | -114.40M | -96.94M | -84.58M | -81.21M |
| Interest Expense | -10.30M | -11.25M | -9.28M | -6.60M | -6.20M | -4.35M |
| Interest & Investment Income | 1.81M | 2.59M | 4.10M | 5.47M | 2.63M | 16.00K |
| Other Non Operating Income (Expenses) | 27.95M | 38.77M | 3.92M | -260.00K | 417.00K | 56.00K |
| EBT Excluding Unusual Items | -90.99M | -77.33M | -115.66M | -98.33M | -87.73M | -85.48M |
| Merger & Restructuring Charges | -700.00K | -700.00K | -49.00K | |||
| Other Unusual Items | -5.04M | 37.20M | -33.05M | -12.44M | 75.77M | 59.06M |
| Pretax Income | -96.73M | -40.83M | -148.70M | -110.78M | -11.96M | -26.48M |
| Net Income | -96.73M | -40.83M | -148.70M | -110.78M | -11.96M | -26.48M |
| Net Income to Common | -96.67M | -40.83M | -148.70M | -110.78M | -11.96M | -26.48M |
| Shares Outstanding (Basic) | 194.45M | 158.16M | 118.48M | 103.42M | 103.05M | 39.97M |
| Shares Outstanding (Diluted) | 194.45M | 158.16M | 118.48M | 103.42M | 103.05M | 39.97M |
| EPS (Basic) | -0.50 | -0.26 | -1.26 | -1.07 | -0.12 | -0.66 |
| EPS (Diluted) | -0.50 | -0.26 | -1.26 | -1.07 | -0.12 | -0.66 |
| Free Cash Flow | -97.56M | -105.93M | -99.69M | -75.58M | -72.18M | -81.41M |
| Free Cash Flow Per Share | -0.50 | -0.67 | -0.84 | -0.73 | -0.70 | -2.04 |
| Operating Margin | -5,207.78% | -5,271.69% | -5,404.35% | -6,429.77% | ||
| Profit Margin | -4,557.66% | -2,003.58% | -764.54% | -2,096.36% | ||
| Free Cash Flow Margin | -4,599.72% | -5,197.55% | -4,611.95% | -6,445.76% | ||
| EBITDA | -103.23M | -100.09M | -107.21M | -89.22M | -76.37M | -72.97M |
| D&A For EBITDA | 7.23M | 7.34M | 7.19M | 7.72M | 8.21M | 8.24M |
| EBIT | -110.46M | -107.44M | -114.40M | -96.94M | -84.58M | -81.21M |
| Revenue as Reported | 2.12M | 2.04M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 79.90M | 50.50M | 44.94M | 80.45M | 149.77M | 217.50M |
| Short-Term Investments | 2.11M | 8.00M | ||||
| Cash & Short-Term Investments | 79.90M | 50.50M | 44.94M | 80.45M | 151.88M | 225.50M |
| Receivables | 330.00K | 441.00K | 31.00K | 176.00K | ||
| Inventory | 6.99M | 13.59M | ||||
| Prepaid Expenses | 5.42M | 3.12M | 2.78M | 2.69M | 2.30M | 3.66M |
| Restricted Cash | 144.00K | 144.00K | 144.00K | 144.00K | ||
| Total Current Assets | 92.79M | 67.80M | 47.86M | 83.28M | 154.21M | 229.34M |
| Property, Plant & Equipment | 44.42M | 47.69M | 39.15M | 44.70M | 49.41M | 57.19M |
| Other Long-Term Assets | 881.00K | 881.00K | 50.86M | 241.00K | 682.00K | |
| Total Assets | 138.09M | 116.37M | 137.87M | 128.22M | 204.30M | 286.53M |
| Accounts Payable | 4.16M | 5.40M | 4.49M | 6.49M | 1.59M | 2.09M |
| Accrued Expenses | 9.27M | 10.54M | 11.42M | 9.34M | 7.11M | 6.76M |
| Current Portion of Long-Term Debt | 885.00K | 8.57M | ||||
| Current Portion of Leases | 1.52M | 2.43M | 2.92M | 2.56M | 2.31M | 2.03M |
| Other Current Liabilities | 238.00K | 53.00K | 173.00K | |||
| Total Current Liabilities | 14.95M | 18.37M | 19.95M | 18.44M | 19.58M | 11.05M |
| Long-Term Debt | 37.02M | 35.94M | 63.65M | 38.60M | 20.34M | 27.36M |
| Long-Term Leases | 28.34M | 26.97M | 14.22M | 16.89M | 19.45M | 21.79M |
| Other Long-Term Liabilities | 26.52M | 31.97M | 92.71M | 40.74M | 28.00M | 104.16M |
| Total Liabilities | 106.83M | 113.26M | 190.54M | 114.68M | 87.37M | 164.36M |
| Common Stock | 28.00K | 20.00K | 13.00K | 10.00K | 10.00K | 10.00K |
| Additional Paid-In Capital | 812.50M | 729.94M | 633.33M | 550.85M | 543.46M | 536.74M |
| Retained Earnings | -781.27M | -726.85M | -686.01M | -537.31M | -426.54M | -414.57M |
| Total Common Equity | 31.26M | 3.11M | -52.67M | 13.55M | 116.93M | 122.17M |
| Shareholders' Equity | 31.26M | 3.11M | -52.67M | 13.55M | 116.93M | 122.17M |
| Total Liabilities & Equity | 138.09M | 116.37M | 137.87M | 128.22M | 204.30M | 286.53M |
| Total Debt | 66.88M | 65.35M | 81.68M | 58.05M | 50.67M | 51.18M |
| Net Cash (Debt) | 13.02M | -14.85M | -36.74M | 22.39M | 101.21M | 174.32M |
| Net Cash Per Share | 0.07 | -0.09 | -0.31 | 0.22 | 0.98 | 4.36 |
| Filing Date Shares Outstanding | 277.80M | 222.02M | 155.12M | 119.08M | 103.33M | 103.00M |
| Total Common Shares Outstanding | 277.80M | 193.00M | 130.03M | 103.67M | 103.23M | 103.00M |
| Working Capital | 77.84M | 49.42M | 27.91M | 64.83M | 134.63M | 218.29M |
| Book Value Per Share | 0.11 | 0.02 | -0.41 | 0.13 | 1.13 | 1.19 |
| Tangible Book Value | 31.26M | 3.11M | -52.67M | 13.55M | 116.93M | 122.17M |
| Tangible Book Value Per Share | 0.11 | 0.02 | -0.41 | 0.13 | 1.13 | 1.19 |
| Machinery | 30.89M | 30.23M | 29.59M | 28.98M | 28.78M | |
| Construction In Progress | 680.00K | |||||
| Leasehold Improvements | 27.97M | 27.90M | 27.84M | 26.36M | 26.36M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -96.73M | -40.83M | -148.70M | -110.78M | -11.96M | -26.48M |
| Depreciation & Amortization | 7.23M | 7.34M | 7.19M | 7.72M | 8.21M | 8.24M |
| Other Amortization | 580.00K | 482.00K | 1.55M | 977.00K | ||
| Loss (Gain) From Sale of Assets | 5.00K | 5.00K | 4.00K | 18.00K | 6.00K | |
| Stock-Based Compensation | 10.71M | 9.75M | 6.14M | 6.83M | 6.18M | 10.15M |
| Other Operating Activities | -6.53M | -57.92M | 36.94M | 15.85M | -76.14M | -73.52M |
| Change in Accounts Receivable | 64.00K | -261.00K | 31.00K | 145.00K | -63.00K | |
| Change in Inventory | -6.55M | -21.83M | ||||
| Change in Accounts Payable | -2.45M | 973.00K | -1.96M | 4.81M | -509.00K | -197.00K |
| Change in Other Net Operating Assets | -3.52M | -2.28M | 2.27M | 1.73M | 1.39M | -297.00K |
| Operating Cash Flow | -97.19M | -105.04M | -98.12M | -73.31M | -71.13M | -81.19M |
| Capital Expenditures | -367.00K | -884.00K | -1.57M | -2.28M | -1.05M | -220.00K |
| Investment in Securities | 2.11M | 5.89M | -8.00M | |||
| Investing Cash Flow | -367.00K | -884.00K | -1.57M | -173.00K | 4.84M | -8.22M |
| Long-Term Debt Issued | 39.78M | 29.66M | ||||
| Long-Term Debt Repaid | -2.80M | -2.58M | -34.07M | -1.98M | -1.73M | |
| Net Debt Issued (Repaid) | 38.22M | 36.98M | -2.58M | -34.07M | -1.98M | 27.93M |
| Issuance of Common Stock | 139.81M | 113.44M | 97.37M | 566.00K | 535.00K | 243.00M |
| Other Financing Activities | -88.60M | -88.94M | 19.39M | 38.01M | -3.94M | |
| Financing Cash Flow | 89.43M | 61.49M | 114.18M | 4.51M | -1.45M | 266.98M |
| Net Cash Flow | -8.13M | -44.44M | 14.49M | -68.97M | -67.73M | 177.57M |
| Free Cash Flow | -97.56M | -105.93M | -99.69M | -75.58M | -72.18M | -81.41M |
| Free Cash Flow Margin | -4,599.72% | -5,197.55% | -4,611.95% | -6,445.76% | ||
| Free Cash Flow Per Share | -0.50 | -0.67 | -0.84 | -0.73 | -0.70 | -2.04 |
| Levered Free Cash Flow | -58.39M | -71.89M | -65.36M | -45.28M | -40.66M | -34.63M |
| Unlevered Free Cash Flow | -52.54M | -64.86M | -59.57M | -41.64M | -38.33M | -32.89M |
| Cash Interest Paid | 1.61M | 2.67M | 1.12M | |||
| Change in Working Capital | -12.46M | -23.39M | 311.00K | 6.57M | 1.03M | -557.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 114.23M | 185.37M | 649.78M | 294.15M | 217.58M | 746.77M |
| Enterprise Value | 101.21M | 216.86M | 708.84M | 251.01M | 96.74M | 548.53M |
| Last Close Price | 0.41 | 0.96 | 5.05 | 2.84 | 2.11 | 7.25 |
| PS Ratio | 53.86 | 90.96 | 139.03 | 591.27 | ||
| PB Ratio | 3.65 | 59.62 | -12.34 | 21.71 | 1.86 | 6.11 |
| P/TBV Ratio | 3.65 | 59.62 | 21.71 | 1.86 | 6.11 | |
| EV/Sales Ratio | 47.72 | 106.41 | 61.81 | 434.31 | ||
| Debt / Equity Ratio | 2.14 | 21.02 | -1.55 | 4.29 | 0.43 | 0.42 |
| Net Debt / Equity Ratio | -0.42 | 4.78 | -0.70 | -1.65 | -0.87 | -1.43 |
| Net Debt / EBITDA Ratio | 0.13 | -0.15 | -0.34 | 0.25 | 1.32 | 2.39 |
| Net Debt / FCF Ratio | 0.13 | -0.14 | -0.37 | 0.30 | 1.40 | 2.14 |
| Asset Turnover | 0.01 | 0.02 | 0.01 | 0.01 | ||
| Quick Ratio | 5.37 | 2.77 | 2.25 | 4.36 | 7.76 | 20.42 |
| Current Ratio | 6.21 | 3.69 | 2.40 | 4.51 | 7.88 | 20.75 |
| Return on Equity (ROE) | -547.87% | -169.81% | -10.01% | -27.46% | ||
| Return on Assets (ROA) | -49.87% | -52.82% | -53.74% | -36.44% | -21.54% | -25.81% |
| Return on Capital Employed (ROCE) | -89.70% | -109.60% | -97.00% | -88.30% | -45.80% | -29.50% |
| Earnings Yield | -120.90% | -22.03% | -22.88% | -37.66% | -5.50% | -3.55% |
| FCF Yield | -85.41% | -57.14% | -15.34% | -25.70% | -33.17% | -10.90% |
| Buyback Yield / Dilution | -45.78% | -33.49% | -14.56% | -0.36% | -157.82% | -593.25% |